/*
 * Mathematical model of paracrine interactions between osteoclasts
 * and osteoblasts predicts anabolic action of parathyroid hormone
 * on bone
 * 
 * Model Status
 * 
 * This CellML model runs in both OpenCell and COR to recreate
 * the published results (figure 2A part 3 the red line). The parameter
 * values have been set to those listed in the main body of the
 * paper with the exception that g12=1.4, k2=0.00075, and g21 increases
 * to 0.15 for one day (day 1-day2). Other figures from the paper
 * can be created by altering these parameter values in the CellML
 * model.
 * 
 * Model Structure
 * 
 * ABSTRACT: To restore falling plasma calcium levels, PTH promotes
 * calcium liberation from bone. PTH targets bone-forming cells,
 * osteoblasts, to increase expression of the cytokine receptor
 * activator of nuclear factor kappaB ligand (RANKL), which then
 * stimulates osteoclastic bone resorption. Intriguingly, whereas
 * continuous administration of PTH decreases bone mass, intermittent
 * PTH has an anabolic effect on bone, which was proposed to arise
 * from direct effects of PTH on osteoblastic bone formation. However,
 * antiresorptive therapies impair the ability of PTH to increase
 * bone mass, indicating a complex role for osteoclasts in the
 * process. We developed a mathematical model that describes the
 * actions of PTH at a single site of bone remodeling, where osteoclasts
 * and osteoblasts are regulated by local autocrine and paracrine
 * factors. It was assumed that PTH acts only to increase the production
 * of RANKL by osteoblasts. As a result, PTH stimulated osteoclasts
 * upon application, followed by compensatory osteoblast activation
 * due to the coupling of osteoblasts to osteoclasts through local
 * paracrine factors. Continuous PTH administration resulted in
 * net bone loss, because bone resorption preceded bone formation
 * at all times. In contrast, over a wide range of model parameters,
 * short application of PTH resulted in a net increase in bone
 * mass, because osteoclasts were rapidly removed upon PTH withdrawal,
 * enabling osteoblasts to rebuild the bone. In excellent agreement
 * with experimental findings, increase in the rate of osteoclast
 * death abolished the anabolic effect of PTH on bone. This study
 * presents an original concept for the regulation of bone remodeling
 * by PTH, currently the only approved anabolic treatment for osteoporosis.
 * 
 * model diagram
 * 
 * [[Image file: komarova_2005.png]]
 * 
 * Schematic representation of the interactions between osteoclasts
 * and osteoblasts included in the model.
 * 
 * The original paper reference is cited below:
 * 
 * Mathematical model of paracrine interactions between osteoclasts
 * and osteoblasts predicts anabolic action of parathyroid hormone
 * on bone, Komarova SV, 2005, Endocrinology, 146, 3589-3595. PubMed
 * ID: 15860557
 */

import nsrunit;
// Warning: unit conversion turned off due to unit errors in 3 equation(s)
unit conversion off;
unit day=86400 second^1;
unit cell = fundamental;
//Warning:  unit percent_ renamed from percent, as the latter is predefined in JSim with different fundamental units.
unit percent_ = fundamental;
unit flux=1.1574074E-5 second^(-1)*cell^1;
unit first_order_rate_constant=1.1574074E-5 second^(-1);
unit second_order_rate_constant=1.1574074E-5 second^(-1)*cell^(-1);
unit percent_per_cell_per_day=1.1574074E-5 second^(-1)*cell^(-1)*percent_^1;
property cellMLNames=string;

math main {
	realDomain time day;
	time.min=0;
	extern time.max;
	extern time.delta;
	real x1(time) cell;
	x1.cellMLNames="x1.x1;x2.x1;y1.x1";
	when(time=time.min) x1=10.06066;
	real alpha1 flux;
	alpha1.cellMLNames="x1.alpha1;model_parameters.alpha1;x1_bar.alpha1;x2_bar.alpha1";
	alpha1=3;
	real beta1 first_order_rate_constant;
	beta1.cellMLNames="x1.beta1;model_parameters.beta1;x1_bar.beta1;x2_bar.beta1";
	beta1=0.2;
	real g11 dimensionless;
	g11.cellMLNames="x1.g11;model_parameters.g11;x2_bar.g11";
	g11=0.5;
	real g21(time) dimensionless;
	g21.cellMLNames="x1.g21;model_parameters.g21;x1_bar.g21";
	real x2(time) cell;
	x2.cellMLNames="x1.x2;x2.x2;y2.x2";
	when(time=time.min) x2=212.132;
	real alpha2 first_order_rate_constant;
	alpha2.cellMLNames="x2.alpha2;model_parameters.alpha2;x1_bar.alpha2;x2_bar.alpha2";
	alpha2=4;
	real beta2 first_order_rate_constant;
	beta2.cellMLNames="x2.beta2;model_parameters.beta2;x1_bar.beta2;x2_bar.beta2";
	beta2=0.02;
//	Var below replaced by constant in model eqns to satisfy unit correction
//	real g12 dimensionless;
//	g12.cellMLNames="x2.g12;model_parameters.g12;x2_bar.g12";
//	g12=1;
//	Var below replaced by constant in model eqns to satisfy unit correction
//	real g22 dimensionless;
//	g22.cellMLNames="x2.g22;model_parameters.g22;x1_bar.g22";
//	g22=0;
	real z(time) percent_;
	z.cellMLNames="z.z";
	when(time=time.min) z=100.0;
	real k1 percent_per_cell_per_day;
	k1.cellMLNames="z.k1;model_parameters.k1";
	k1=0.24;
	real k2 percent_per_cell_per_day;
	k2.cellMLNames="z.k2;model_parameters.k2";
	k2=0.0017;
	real y1(time) cell;
	y1.cellMLNames="z.y1;y1.y1";
	real y2(time) cell;
	y2.cellMLNames="z.y2;y2.y2";
	real x1_bar(time) cell;
	x1_bar.cellMLNames="y1.x1_bar;x1_bar.x1_bar";
	real x2_bar(time) cell;
	x2_bar.cellMLNames="y2.x2_bar;x2_bar.x2_bar";
	real gamma(time) dimensionless;
	gamma.cellMLNames="x1_bar.gamma;model_parameters.gamma;x2_bar.gamma";

	// <component name="environment">

	// <component name="x1">
	x1:time=(alpha1*x1^g11*x2^g21-beta1*x1);

	// <component name="x2">
	x2:time=(alpha2*x1^1*x2^0-beta2*x2);

	// <component name="z">
	z:time=(k2*y2-k1*y1);

	// <component name="y1">
	y1=(if (x1>x1_bar) x1-x1_bar else (0 cell));

	// <component name="y2">
	y2=(if (x2>x2_bar) x2-x2_bar else (0 cell));

	// <component name="x1_bar">
	x1_bar=((beta1/alpha1)^((1-0)/gamma)*(beta2/alpha2)^(g21/gamma));

	// <component name="x2_bar">
	x2_bar=((beta1/alpha1)^(1/gamma)*(beta2/alpha2)^((1-g11)/gamma));

	// <component name="model_parameters">
	gamma=(1*g21-(1-g11)*(1-0));
	g21=(if ((time>=(1 day)) and (time<(2 day))) .15 else -0.5);
}

